日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Lodderomyces elongisporus Mitochondrial outer membrane protein IML2 (IML2), partial CSB-YP398955LLV
CSB-EP398955LLV
CSB-BP398955LLV
CSB-MP398955LLV
CSB-EP398955LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Topoisomerase 1-associated factor 1 (TOF1), partial CSB-YP398956LLV
CSB-EP398956LLV
CSB-BP398956LLV
CSB-MP398956LLV
CSB-EP398956LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus PAB-dependent poly (A)-specific ribonuclease subunit PAN3, partial CSB-YP398957LLV
CSB-EP398957LLV
CSB-BP398957LLV
CSB-MP398957LLV
CSB-EP398957LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Cell division cycle protein 123 (CDC123) CSB-YP398958LLV
CSB-EP398958LLV
CSB-BP398958LLV
CSB-MP398958LLV
CSB-EP398958LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus ATP-dependent RNA helicase SUB2 (SUB2) CSB-YP398959LLV
CSB-EP398959LLV
CSB-BP398959LLV
CSB-MP398959LLV
CSB-EP398959LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus SWI5-dependent HO expression protein 3 (SHE3) CSB-YP398960LLV
CSB-EP398960LLV
CSB-BP398960LLV
CSB-MP398960LLV
CSB-EP398960LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus Lysophospholipase NTE1 (NTE1), partial CSB-YP398961LLV
CSB-EP398961LLV
CSB-BP398961LLV
CSB-MP398961LLV
CSB-EP398961LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lodderomyces elongisporus tRNA (guanine-N (7)-)-methyltransferase CSB-YP398962LLV
CSB-EP398962LLV
CSB-BP398962LLV
CSB-MP398962LLV
CSB-EP398962LLV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP398963BPE
CSB-EP398963BPE
CSB-BP398963BPE
CSB-MP398963BPE
CSB-EP398963BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. Integration host factor subunit beta (ihfB) CSB-YP398964BPE
CSB-EP398964BPE
CSB-BP398964BPE
CSB-MP398964BPE
CSB-EP398964BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP398965BPE
CSB-EP398965BPE
CSB-BP398965BPE
CSB-MP398965BPE
CSB-EP398965BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP398966BPE
CSB-EP398966BPE
CSB-BP398966BPE
CSB-MP398966BPE
CSB-EP398966BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP398967BPE
CSB-EP398967BPE
CSB-BP398967BPE
CSB-MP398967BPE
CSB-EP398967BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. Ribonuclease PH (rph) CSB-YP398968BPE
CSB-EP398968BPE
CSB-BP398968BPE
CSB-MP398968BPE
CSB-EP398968BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. 50S ribosomal protein L20 (rplT) CSB-YP398969BPE
CSB-EP398969BPE
CSB-BP398969BPE
CSB-MP398969BPE
CSB-EP398969BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP398970BPE
CSB-EP398970BPE
CSB-BP398970BPE
CSB-MP398970BPE
CSB-EP398970BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP398971BPE
CSB-EP398971BPE
CSB-BP398971BPE
CSB-MP398971BPE
CSB-EP398971BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. Probable intracellular septation protein A (BBta_0376), partial CSB-YP398972BPE1
CSB-EP398972BPE1
CSB-BP398972BPE1
CSB-MP398972BPE1
CSB-EP398972BPE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. ATP synthase gamma chain (atpG) CSB-YP398973BPE
CSB-EP398973BPE
CSB-BP398973BPE
CSB-MP398973BPE
CSB-EP398973BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium sp. Glutamate 5-kinase (proB) CSB-YP398974BPE
CSB-EP398974BPE
CSB-BP398974BPE
CSB-MP398974BPE
CSB-EP398974BPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×